DarioHealth Corp reports results for the quarter ended in March - Earnings Summary

DarioHealth

15/05/2024 14:51

* DarioHealth Corp  DRIO.OQ  reported a quarterly adjusted
loss
of 20 cents​​ per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -45 cents.  The mean expectation of two analysts for the
quarter was for a loss of 40 cents per share. Wall Street
expected results to range from -59 cents to -22 cents per share.
    * Revenue fell 18.5% to $5.76 million from a year ago;
analysts
expected $6.76 million. 
    * DarioHealth Corp's reported EPS for the quarter was a loss
of 20
cents​.
    * The company reported a quarterly loss of $7.18 million.
    * DarioHealth Corp shares had risen by 13.1% this
quarter and
gained 0.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 19% in
the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for DarioHealth Corp
is $5.00 
This summary was machine generated from LSEG data May 15 at
01:50 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.40          -0.20          Beat
 Dec. 31 2023      -0.55          -0.50          Beat
 Sep. 30 2023      -0.46          -0.49          Missed
 Jun. 30 2023      -0.52          -0.58          Missed